Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLibertine Hold Regulatory News (LIB)

  • This share is currently suspended. It was suspended at a price of 1.165
  • There is currently no data for LIB

Holding(s) in Company

13 Jan 2023 15:56

RNS Number : 7277M
Libertine Holdings PLC
13 January 2023
 

13 January 2023

 

Libertine Holdings Plc

("Libertine" or the "Company")

 

Notification of transaction of Directors / Persons Discharging Managerial Responsibility

 

Libertine Holdings PLC (LSE AIM: LIB) announces that it has been notified today of the following transaction in the ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares").

 

Peter Wright, Non-executive Director, bought 78,071 Ordinary Shares at a price of £0.16 pence per share. Following this notification, Peter's total beneficial holding is 78,071 Ordinary Shares representing 0.06% of the Company's issued share capital and 0.06% of the Company's total voting rights.

 

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail in respect of the transactions described above.

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Peter Wright

2

Reason for the notification

a)

Position/status:

Non-executive Director

b)

Initial notification/Amendment:

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Libertine Holdings plc

b)

LEI:

21380075YD7B9K4FKN15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.1p each

 

ISIN: GB00BN6PSG15 LIB.L

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

16p

78,071

d)

Aggregated information:

· Aggregated volume:

· Price:

 

78,071

16p

e)

Date of the transaction:

12 January 2023

f)

Place of the transaction:

 XLON-AIM

 

 

 

For more information, please visit www.libertine.co.uk or contact:

 

Libertine Holdings PLC

via Tavistock

Sam Cockerill, Chief Executive Officer

Gareth Hague, Chief Financial Officer

Panmure Gordon (NOMAD and Broker)

+44 20 7886 2500

John Prior

Dougie McLeod

Hugh Rich (Corporate Broking)

Tavistock (Public Relations and Investor Relations)

+44 207 920 3150 

Simon Hudson

libertine@tavistock.co.uk

Rebecca Hislaire

Charles Baister 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBJMATMTABBJJ
12
Date   Source Headline
30th Sep 20247:00 amRNSCancellation - Libertine Holdings plc
28th Aug 20243:44 pmRNSAppointment of Administrators & Nomad Resignation
19th Aug 20247:00 amRNSFinancing Update
7th Aug 20242:00 pmRNSEngagement of Interpath Advisory
31st Jul 20242:18 pmRNSFinancing Update
29th Jul 20241:02 pmRNSFinancing Update & Suspension of Trading in Shares
29th Jul 202412:50 pmRNSSuspension - Libertine Holdings plc
16th Jul 20247:00 amRNSFinancing Update
1st Jul 20247:00 amRNSFinancing Update
20th Jun 20244:38 pmRNSFinancing Update
13th Jun 20247:00 amRNSUpdate on Strategic Review & Formal Sale Process
5th Jun 20249:31 amRNSForm 8.5 (EPT/RI)
28th May 20248:35 amRNSForm 8.5 (EPT/RI)
24th May 20249:47 amRNSForm 8.5 (EPT/RI)
21st May 20244:30 pmRNSUpdate on Strategic Review & Formal Sale Process
21st May 20241:09 pmRNSForm 8.3 - Libertine Holdings plc
17th May 20242:33 pmRNSForm 8.3 - Libertine Holdings plc
16th May 20242:36 pmRNSForm 8.3 - Libertine Holdings plc
13th May 202410:03 amRNSForm 8.5 (EPT/RI)
13th May 20247:00 amRNSStrategic Partnership Agreement with Vieletech Inc
10th May 202410:07 amRNSForm 8.3 - Libertine Holdings plc
8th May 20242:49 pmRNSForm 8.3 - Libertine Holdings plc
8th May 202412:52 pmGNWForm 8.3 - Libertine Holdings plc
3rd May 20247:00 amRNSForm 8 (OPD) (Libertine Holdings plc)
30th Apr 202410:50 amRNSForm 8 (OPD) (Libertine Holdings plc)
30th Apr 20247:06 amRNSForm 8.3 - Libertine Holdings plc
29th Apr 20249:23 amRNSForm 8.5 (EPT/RI)
29th Apr 20247:00 amRNSStrategic Review & Formal Sale Process
25th Mar 20247:00 amRNSStrategic Partnership Agreement with LHP
22nd Mar 202412:21 pmRNSTrading Update
12th Mar 20247:00 amRNSStrategic Partnership Agreement with BASEBATT
9th Feb 20244:07 pmRNSHolding(s) in Company
7th Feb 20246:30 pmRNSCompletion of support and license to Hyliion
19th Dec 20237:00 amRNSHalf year results
15th Dec 20237:00 amRNSNotice of Results
10th Nov 20237:00 amRNSResult of AGM
9th Nov 20237:00 amRNSTrading Update
6th Oct 20231:39 pmRNSNotice of Annual Report and Annual General Meeting
28th Sep 20237:00 amRNSFinal Results
26th Sep 20237:00 amRNSNotice of Results
1st Sep 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSTrading Update
22nd Feb 20237:00 amRNSImplementation of Long Term Incentive Plan
16th Feb 20237:00 amRNSSigning of Term Sheet with Azelio AB
13th Jan 20233:56 pmRNSHolding(s) in Company
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:05 pmRNSSecond Price Monitoring Extn
15th Dec 20222:00 pmRNSPrice Monitoring Extension
15th Dec 20227:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.